Published in Small on September 01, 2008
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A (2010) 3.03
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) (2009) 2.30
Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia. ACS Nano (2011) 1.48
Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release (2011) 1.09
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond) (2010) 1.04
Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem (2014) 0.97
Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev (2013) 0.97
Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater (2012) 0.95
Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.91
Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A (2013) 0.90
Oligonucleotide delivery by cell-penetrating "striped" nanoparticles. Angew Chem Int Ed Engl (2011) 0.89
Novel molecular and nanosensors for in vivo sensing. Theranostics (2013) 0.89
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery. Adv Funct Mater (2013) 0.87
Biotargeted nanomedicines for cancer: six tenets before you begin. Nanomedicine (Lond) (2013) 0.85
Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake. Nano Lett (2014) 0.84
Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles. Mol Imaging (2011) 0.84
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.84
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors. Nano Today (2013) 0.80
Insights into atherosclerosis using nanotechnology. Curr Atheroscler Rep (2010) 0.80
Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine. Mol Cells (2013) 0.78
Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology. Trends Biotechnol (2014) 0.78
siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells. Biosci Rep (2015) 0.76
Smart nanosystems: Bio-inspired technologies that interact with the host environment. Proc Natl Acad Sci U S A (2015) 0.76
CPP-Assisted Intracellular Drug Delivery, What Is Next? Int J Mol Sci (2016) 0.75
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A (2007) 5.17
Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A (2004) 4.95
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (1997) 4.83
Multifunctional nanocarriers. Adv Drug Deliv Rev (2006) 4.46
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res (2006) 4.43
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem (1999) 4.41
In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med (2001) 4.30
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A (2000) 2.47
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev (2004) 1.90
Super pH-sensitive multifunctional polymeric micelle. Nano Lett (2005) 1.75
On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev (2004) 1.71
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther (2006) 1.51
Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed Engl (2006) 1.39
Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res (1993) 1.39
Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. Bioconjug Chem (2004) 1.29
Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate. Bioconjug Chem (2001) 1.28
Protease-modulated cellular uptake of quantum dots. Nano Lett (2006) 1.19
New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem (1999) 1.13
Nanoparticle self-assembly gated by logical proteolytic triggers. J Am Chem Soc (2007) 1.11
"Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J Liposome Res (2007) 1.09
Drug-polymer conjugates containing acid-cleavable bonds. Crit Rev Ther Drug Carrier Syst (1999) 1.07
MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol (1999) 1.02
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim Biophys Acta (2002) 0.99
Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers. Pharmacol Res (2004) 0.97
Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications. Chem Phys Lipids (1999) 0.95
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J Control Release (2004) 0.89
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A (2007) 3.53
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods (2006) 3.20
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J (2006) 2.95
Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy. J Am Chem Soc (2005) 2.56
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg (2013) 2.31
Nanowire-based single-cell endoscopy. Nat Nanotechnol (2011) 2.27
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng (2009) 2.16
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest (2006) 2.14
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Electron vortex beams with high quanta of orbital angular momentum. Science (2011) 2.01
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol (2010) 1.99
Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc (2007) 1.98
Cancer vulnerabilities unveiled by genomic loss. Cell (2012) 1.95
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Delivery of nanogram payloads using magnetic porous silicon microcarriers. Lab Chip (2006) 1.93
Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones. Nat Mater (2004) 1.89
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir (2004) 1.81
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Microfabricated platform for studying stem cell fates. Biotechnol Bioeng (2004) 1.77
Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev (2008) 1.76
Three-dimensional tissue fabrication. Adv Drug Deliv Rev (2004) 1.76
Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science (2003) 1.72
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Selective immobilization of proteins to self-assembled monolayers presenting active site-directed capture ligands. Proc Natl Acad Sci U S A (2002) 1.63
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2012) 1.62
Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano (2011) 1.61
Biomedical applications of graphene and graphene oxide. Acc Chem Res (2013) 1.60
Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA (2005) 1.59
Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano (2012) 1.58
Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng (2003) 1.58
Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng (2003) 1.58
The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol (2012) 1.56
Intracranial arachnoid cysts: current concepts and treatment alternatives. Clin Neurol Neurosurg (2007) 1.55
Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study. JAMA Otolaryngol Head Neck Surg (2013) 1.54
Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci U S A (2010) 1.53
Engineering protein and cell adhesivity using PEO-terminated triblock polymers. J Biomed Mater Res (2002) 1.50
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49
A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun (2012) 1.47
Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip (2004) 1.46
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2011) 1.44
Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles. ACS Nano (2008) 1.44
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol (2010) 1.40
Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol (2010) 1.40
Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed Engl (2006) 1.39
Smart dust: self-assembling, self-orienting photonic crystals of porous Si. Proc Natl Acad Sci U S A (2003) 1.39
The role of proximal pH monitoring. Am J Gastroenterol (2005) 1.38
Tissue-specific gene delivery via nanoparticle coating. Biomaterials (2009) 1.34
Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology (2009) 1.33
Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng (2004) 1.32